New Research on Potent HIV Antibody Could Improve Vaccine Design Early mutation in neutralizing antibody gives it flexibility to adapt to virus’ changes
A Shortcut to Recreate Key HIV Antibody for Vaccines With new insights about the antibody’s pathway, researchers can bypass a previous hurdle
Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies The finding advances efforts to develop a vaccine that elicits protective HIV antibodies
Blue Devil of the Week: Leading Safety for the Human Vaccine Institute Scott Alderman ensures employees and students are safe when handling potentially infectious materials Name: Scott Alderman Title: Director of Safety for the Duke Human Vaccine...
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections Population-based model would benefit research and public health initiatives worldwide
Duke Institute Tapped to Build a Rapid-Response System for Viral Pandemics Existing components at the Duke Human Vaccine Institute form the effort’s infrastructure
Antibodies Halt Placental Transmission of CMV-Like Virus in Monkeys The finding advances a human vaccine for CMV, which afflicts 1 million babies a year
Investigational Vaccine Protected Monkeys from HIV-Like Virus The vaccine adds three more targets to a human vaccine candidate that showed promise
